MedPath

Progressive Mobilization With Dose Control and Training Load in in Critically Ill Patients

Not Applicable
Conditions
Critically Ill
Interventions
Other: Progressive mobilization
Other: Usual Care
Registration Number
NCT03596853
Lead Sponsor
Federal University of Bahia
Brief Summary

Immobilization and bed rest of patients in intensive care units (ICU) increases their risk for muscle dysfunction and prolonged mechanical ventilation, leading to physical deconditioning and loss of functionality. Active mobilization is a therapeutic strategy that typically involves exercises in which the patient uses his or her own strength and muscular control, is a feasible, safe, and low-cost intervention to improve muscle dysfunction and disability in patients at the ICU. Despite scientific advances, the current description and prescriptions of exercises at the ICU remain incomplete with respect to the control and the description of the variables of training load (volume and intensity), programming, and progression.

Detailed Description

This prospective double-blind (patient and evaluator). This study will be conducted in accordance with Consolidated Standards of Reporting Trials recommendations. The trial will be performed at the University Hospital Professor Edgard Santos in Salvador, Bahia, Brazil. This study was approved by the institutional hospital ethics committee (approval reference number 2.371.933). Before enrollment, written informed consent will be obtained from participants or their legal guardians.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
104
Inclusion Criteria
  • Being able to roll in the bed and bridge.
  • Barthel score of at least 70 weeks before admission to the ICU
  • Ability to interact with the researcher
Exclusion Criteria
  • Mortality rate in excess of 50% according to Acute Physiology and Chronic Health Disease Classification System II (APACHEII)
  • Present intracranial pressure increase
  • Cardiorespiratory arrest,
  • Has unstable fractures that hamper progression in levels of mobilization,
  • Severe lower limb injury or amputation
  • Neuromuscular disease
  • Underwent radiotherapy and / or chemotherapy in the last 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental: MobilizationProgressive mobilizationThese patients will receive standard rehabilitation delivered by non-study physiotherapist. In addition, the patients will undergo a protocol of progressive mobilization with individualized dose control and training load stratified according to functional levels and performance.
Control: Usual careUsual CareThese patients will receive standard rehabilitation delivered by non-study physiotherapist.
Primary Outcome Measures
NameTimeMethod
Length of ICU stay in daysat 28 days or discharge from ICU whichever occurs earlier

Time in days, from baseline to discharge from ICU

Secondary Outcome Measures
NameTimeMethod
Surgical Optimal Mobilisation Score (SOMS) levelChange from baseline up to 28th day or discharge from hospital

Surgical Optimal Mobilisation Score (SOMS) level algorithm for goal-directed mobility ranges from '0-No mobility' to '4-Ambulation'. The intermediate steps are '1-Passive Range of Motion,' '2-Sitting,' and '3-Standing.'

Muscle massChange from baseline at 28th day

Ultrasound measurement (quadriceps, biceps brachii, and diaphragm - cross-sectional area on B-mode ultrasound

Muscle thicknessChange from baseline at 28th day

Ultrasound measurement (quadriceps, biceps brachii, and diaphragm on B-mode ultrasound measured in mm

Change in muscle strengthBaseline and after 3 and at 7 day intervals up to 28th day or discharge from ICU

Muscle Strength measured by hand held dynamometer

Physical activity: total activityAt 28 days or discharge from hospital

accelerometry measurement of the total activity

MortalityAt 28 days or discharge from hospital and at 12 months

Mortality

Days with mechanical ventilationFrom 3 to 28 days

Number of uninterrupted days in use of mechanical ventilation

Length of hospital stay in daysUp to 1 month post hospital discharge

Time in days, from baseline to discharge from hospital

MobilityChange from baseline up to 28th day or discharge from hospital

Timed up-and-go score

Health-Related Quality of Life: SF-36At 28 days or discharge from hospital and at 12 months

Health-Related Quality of Life will be measured by a questionnaire 36-item Short Form Health Survey. The SF-36 is a widely used generic instrument for evaluating HRQoL, consisting of eight subscales evaluating specific health status domains and two summary scales, a Physical Component Summary and a Mental Component Summary. Scores on the SF-36 range from 0 to 100, with higher scores indicating better health status.

Activity and participationChange from baseline up to 1 year post discharge

Measurement characteristics of World Health Organisation Disability Assessment Schedule II

Functional StatusChange from baseline up to 28th day or discharge from hospital

Functional Status Measured Using Functional Status Score for the Intensive Care Unit (involves five functional tasks (rolling, supine to sit transfer, sit to stand transfer, sitting on the edge of bed and walking). Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform at all) to 7 (complete independence)

Trial Locations

Locations (1)

Mansueto Gomes Neto

🇧🇷

Salvador, Bahia, Brazil

© Copyright 2025. All Rights Reserved by MedPath